Breast cancer, Cancer spread to the bone, Secondary cancers
Results
Phase 1/2
This trial looked at capecitabine and a type of internal radiotherapy called radium-223. It was for women with breast cancer that had spread to the bones.
The study was open for people to join between 2016 and 2019. The team published the results in 2022.
Recruitment start: 28 September 2016
Recruitment end: 20 March 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Janet Brown
Bayer
Experimental Cancer Medicine Centre (ECMC)
Yorkshire Cancer Research
NIHR Clinical Research Network: Cancer
Sheffield Teaching Hospitals NHS Foundation Trust
University of Leeds
University of Sheffield
Last reviewed: 21 February 2023
CRUK internal database number: 13882
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
